# Altria on The No Agenda Show Altria comes up in 10 chapters across 9 episodes of The No Agenda Show, from February 2019 to October 2022. - **Chapters:** 10 - **Episodes:** 9 - **Discussed:** February 2019 – October 2022 - **Related topics:** [Juul](https://search.noagendashow.net/topic/juul.md), [Vaping](https://search.noagendashow.net/topic/vaping.md), [Fda](https://search.noagendashow.net/topic/fda.md), [Iqos](https://search.noagendashow.net/topic/iqos.md), [Philip Morris](https://search.noagendashow.net/topic/philip-morris.md), [Nicotine](https://search.noagendashow.net/topic/nicotine.md), [Ace2](https://search.noagendashow.net/topic/ace2.md), [Big Tobacco](https://search.noagendashow.net/topic/big-tobacco.md), [Charlie Baker](https://search.noagendashow.net/topic/charlie-baker.md), [E-cigarettes](https://search.noagendashow.net/topic/e-cigarettes.md) ## Chapters 1–10 of 10 ### Altria Philip Morris Deal, Vape Market Transition - **Episode:** [1496: Deport Greta](https://search.noagendashow.net/episode/1496-deport-greta.md) - **Published:** 2022-10-20 - **Time:** 2:21:55–2:23:33 - **Transcript:** https://search.noagendashow.net/episode/1496-deport-greta/chapter/altria-philip-morris-deal-vape-market-transition.md Altria sold its US rights for the IQOS heated tobacco system to Philip Morris for $2.7 billion. This move signals a shift away from liquid-based vapes toward tobacco-based "smokeless" products. The transition is seen as a way to protect the tobacco bond market and state tax revenues which were threatened by the rise of independent vaping companies. Keywords: [altria](https://search.noagendashow.net/topic/altria.md), [philip morris](https://search.noagendashow.net/topic/philip-morris.md), [iqos](https://search.noagendashow.net/topic/iqos.md), [vaping](https://search.noagendashow.net/topic/vaping.md), tobacco bonds ### Vape Wars Update, FDA Synthetic Nicotine Regulation - **Episode:** [1391: Clown World](https://search.noagendashow.net/episode/1391-clown-world.md) - **Published:** 2021-10-17 - **Time:** 2:42:20–2:46:02 - **Transcript:** https://search.noagendashow.net/episode/1391-clown-world/chapter/vape-wars-update-fda-synthetic-nicotine-regulation.md A tobacco lawyer provided feedback on the "Vape Wars," clarifying the status of Juul's FDA application and the rise of synthetic nicotine as a way for small manufacturers to bypass current regulations. The discussion covers the Master Settlement Agreement and the influence of Big Tobacco on the industry. Keywords: [vaping](https://search.noagendashow.net/topic/vaping.md), [fda](https://search.noagendashow.net/topic/fda.md), [juul](https://search.noagendashow.net/topic/juul.md), [altria](https://search.noagendashow.net/topic/altria.md), synthetic nicotine ### S1 Spike Proteins, Nicotine and ACE2 Receptors - **Episode:** [1369: COVID Roulette](https://search.noagendashow.net/episode/1369-covid-roulette.md) - **Published:** 2021-08-01 - **Time:** 1:17:05–1:21:01 - **Transcript:** https://search.noagendashow.net/episode/1369-covid-roulette/chapter/s1-spike-proteins-nicotine-and-ace2-receptors.md Research into the S1 spike protein suggests it may be the primary driver of COVID-19 pathology. Some theories, previously discussed in early 2020, suggest that nicotine may interact with ACE2 receptors to prevent viral entry. While these claims were largely suppressed, tobacco giant Altria has recently expanded into medical inhalers and nicotine gum, signaling a potential shift toward therapeutic applications. Keywords: [spike protein](https://search.noagendashow.net/topic/spike-protein.md), [nicotine](https://search.noagendashow.net/topic/nicotine.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [altria](https://search.noagendashow.net/topic/altria.md), [ace2](https://search.noagendashow.net/topic/ace2.md), s1 protein ### Vape Wars, Altria and the IQOS Smokeless Device - **Episode:** [1264: Mask Debate](https://search.noagendashow.net/episode/1264-mask-debate.md) - **Published:** 2020-07-30 - **Time:** 2:15:20–2:19:12 - **Transcript:** https://search.noagendashow.net/episode/1264-mask-debate/chapter/vape-wars-altria-and-the-iqos-smokeless-device.md Altria is reportedly pivoting toward its new "IQOS" smokeless tobacco device after the systematic dismantling of the e-cigarette and Juul markets. The move is seen as an attempt to maintain tax revenue for states under the Master Settlement Agreement, which traditional vaping threatened. Critics predict the device will fail because it removes the social and sensory element of "blowing smoke" that users enjoy. Keywords: [altria](https://search.noagendashow.net/topic/altria.md), [iqos](https://search.noagendashow.net/topic/iqos.md), [juul](https://search.noagendashow.net/topic/juul.md), smokeless tobacco, [master settlement agreement](https://search.noagendashow.net/topic/master-settlement-agreement.md) ### FDA, Philip Morris IQOS Approval - **Episode:** [1175: Son of a Biden](https://search.noagendashow.net/episode/1175-son-of-a-biden.md) - **Published:** 2019-11-28 - **Time:** 2:22:21–2:26:14 - **Transcript:** https://search.noagendashow.net/episode/1175-son-of-a-biden/chapter/fda-philip-morris-iqos-approval.md The FDA has cleared Philip Morris's IQOS heated tobacco device for sale in the United States. Unlike traditional vapes, the IQOS heats actual tobacco "heat sticks" without combustion, representing Big Tobacco's strategy to maintain its core business while moving away from traditional cigarettes. Keywords: [fda](https://search.noagendashow.net/topic/fda.md), [philip morris](https://search.noagendashow.net/topic/philip-morris.md), [iqos](https://search.noagendashow.net/topic/iqos.md), [altria](https://search.noagendashow.net/topic/altria.md), heated tobacco ### Juul CEO Resignation, Massachusetts Vaping Ban - **Episode:** [1176: Soest Piet](https://search.noagendashow.net/episode/1176-soest-piet.md) - **Published:** 2019-09-29 - **Time:** 1:26:46–1:31:27 - **Transcript:** https://search.noagendashow.net/episode/1176-soest-piet/chapter/juul-ceo-resignation-massachusetts-vaping-ban.md Juul Labs CEO Kevin Burns resigned as the company suspended all advertising and lobbying efforts in the U.S. This coincides with Massachusetts Governor Charlie Baker declaring a four-month ban on all vaping products following a spike in lung illnesses. The industry shift occurs as major tobacco companies pivot toward new "heated tobacco" technologies. Keywords: [juul](https://search.noagendashow.net/topic/juul.md), kevin burns, [charlie baker](https://search.noagendashow.net/topic/charlie-baker.md), [massachusetts](https://search.noagendashow.net/topic/massachusetts.md), [altria](https://search.noagendashow.net/topic/altria.md) ### IQOS Launch, Philip Morris and Altria Merger Collapse - **Episode:** [1176: Soest Piet](https://search.noagendashow.net/episode/1176-soest-piet.md) - **Published:** 2019-09-29 - **Time:** 1:31:26–1:35:13 - **Transcript:** https://search.noagendashow.net/episode/1176-soest-piet/chapter/iqos-launch-philip-morris-and-altria-merger-collapse.md Philip Morris International (PMI) and Altria ended merger discussions to focus on the U.S. launch of IQOS, a heated tobacco device already approved by the FDA. Critics suggest the recent vaping health scare was leveraged by the tobacco industry to destroy independent vape competitors. During a congressional hearing, Representative Rashida Tlaib questioned a vape advocate's motives, accusing her of being a conspiracy theorist. Keywords: [iqos](https://search.noagendashow.net/topic/iqos.md), [philip morris](https://search.noagendashow.net/topic/philip-morris.md), [altria](https://search.noagendashow.net/topic/altria.md), [rashida tlaib](https://search.noagendashow.net/topic/rashida-tlaib.md), [fda](https://search.noagendashow.net/topic/fda.md) ### Juul Labs, Big Tobacco Vaping Lobbying Strategy - **Episode:** [1171: Slutty Vegan](https://search.noagendashow.net/episode/1171-slutty-vegan.md) - **Published:** 2019-09-12 - **Time:** 9:26–14:51 - **Transcript:** https://search.noagendashow.net/episode/1171-slutty-vegan/chapter/juul-labs-big-tobacco-vaping-lobbying-strategy.md Juul Labs, partially owned by Altria (formerly Philip Morris), is accused of utilizing Big Tobacco's historical playbook to secure market dominance through state-level legislation. The company employs hundreds of lobbyists to push for state laws that preempt local city ordinances, effectively making it harder for independent vape shops to operate. This strategy aims to position Juul as the primary FDA-approved option while eliminating smaller competitors. Keywords: juul labs, [philip morris](https://search.noagendashow.net/topic/philip-morris.md), [altria](https://search.noagendashow.net/topic/altria.md), [lobbying](https://search.noagendashow.net/topic/lobbying.md), [vaping](https://search.noagendashow.net/topic/vaping.md) ### Vaping Industry Regulations, PMTA Deadlines and Juul Investment - **Episode:** [1170: Generational Justce](https://search.noagendashow.net/episode/1170-generational-justce.md) - **Published:** 2019-09-08 - **Time:** 1:07:41–1:12:54 - **Transcript:** https://search.noagendashow.net/episode/1170-generational-justce/chapter/vaping-industry-regulations-pmta-deadlines-and-juul-investment.md Cynthia Cabrera, a veteran of the vapor trade association, clarified that the FDA has not yet approved any vaping products. By May 10, 2020, all products without a Pre-Market Tobacco Application (PMTA) will be considered illegal, a process costing roughly $1 million per flavor. Despite Altria's $13 billion investment for a 30% stake in Juul, they do not hold a board seat, and the industry faces a "regulatory shitstorm" fueled by media reports on lung illnesses. Keywords: [fda](https://search.noagendashow.net/topic/fda.md), pmta, [juul](https://search.noagendashow.net/topic/juul.md), [altria](https://search.noagendashow.net/topic/altria.md), [vaping](https://search.noagendashow.net/topic/vaping.md), [nicotine](https://search.noagendashow.net/topic/nicotine.md) ### Big Tobacco and Vaping, Altria Acquisition of Juul - **Episode:** [1109: Pentacon](https://search.noagendashow.net/episode/1109-pentacon.md) - **Published:** 2019-02-05 - **Time:** 35:02–41:13 - **Transcript:** https://search.noagendashow.net/episode/1109-pentacon/chapter/big-tobacco-and-vaping-altria-acquisition-of-juul.md Altria, the parent company of Philip Morris, has acquired a significant stake in the vape company Juul for $13 billion. A new study published in the New England Journal of Medicine claims e-cigarettes are twice as effective as traditional nicotine replacement therapies for quitting smoking. This marketing shift is compared to Edward Bernays' historical PR campaigns for the tobacco industry, rebranding "Big Tobacco" as "Big Nick." Keywords: [altria](https://search.noagendashow.net/topic/altria.md), [juul](https://search.noagendashow.net/topic/juul.md), [vaping](https://search.noagendashow.net/topic/vaping.md), [nicotine](https://search.noagendashow.net/topic/nicotine.md), [big tobacco](https://search.noagendashow.net/topic/big-tobacco.md), [edward bernays](https://search.noagendashow.net/topic/edward-bernays.md), [e-cigarettes](https://search.noagendashow.net/topic/e-cigarettes.md) --- This is the markdown version of a page on The No Agenda Show for AI agents. Every public page on this site has one: add `.md` to its URL, or request it with `Accept: text/markdown`. - [Site index for agents (llms.txt)](https://search.noagendashow.net/llms.txt) - [Home](https://search.noagendashow.net/index.md) - [Search transcripts](https://search.noagendashow.net/search.md) - [All episodes](https://search.noagendashow.net/episodes.md) - [Topics](https://search.noagendashow.net/topics.md) - [People](https://search.noagendashow.net/people.md)